LMG Life Sciences Awards EMEA 2023 shortlist revealed

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

LMG Life Sciences Awards EMEA 2023 shortlist revealed

LMG-LS-2023-EMEA-logo-article

The LMG Life Sciences Awards is excited to announce its shortlist for the 2023 EMEA Awards.

The LMG Life Sciences Awards has released the full list of finalists for the 2023 EMEA awards.

The awards bring together Europe’s legal community to recognise the leading law firms and lawyers from across the region to celebrate their success in the Life Sciences industry.

Winners will be announced at the black-tie gala celebration which will be held on 13 July 2023 at the Waldorf Hilton.

A preview of the finalists can be found below and the full list of the finalists for all categories is available on the LMG Life Sciences website. The LMG Life Sciences Awards research team carefully selected each finalist after a thorough research period which included an analysis of direct submissions, client feedback, and much deliberation.

Individual practitioners and Rising Stars are judged not only on the complexity of the work the nominees completed in 2022, but also on their advocacy, influence, and thought leadership.

All of the work accepted for shortlisting closed during the research period, which was from January 1 to December 31 2022. The awards do not recognise cases, deals, or transactions completed outside of the research period.

If you have any questions regarding our research process, please contact our editor John Harrison

The LMG Life Sciences Awards will be announcing the winners on July 13 at a live awards gala. To find out more – and to find out about how you can promote your success – please contact Prin Shasiharan.

Preview of the LMG Life Sciences Awards EMEA 2023 shortlist:

  • Patent Litigation Firm of the Year: Biologics & Biosimilars

    Allen & Overy
    Carpmaels & Ransford
    DORDA
    Herbert Smith Freehills
    Pestalozzi Attorneys at Law
    Powell Gilbert
    Taylor Wessing
  • Patent Strategy & Management Firm of the Year

    Bird & Bird
    Deris Attorney at Law Partnership
    Dimitrov Petrov & Co
    Greenberg Traurig
    Kiortsis & Associates
    NSN Law Firm
    The Luzzatto Group
  • Patent Litigator of the Year: Biologics & Biosimilars

    Andreas Seling
    DORDA
    Andri Hess
    Homburger
    David Wilson
    Carpmaels & Ransford
    Emre Kerim Yardimci
    Deris Attorney at Law Partnership
    Laura Orlando
    Herbert Smith Freehills
    Patricia Cappuyns
    Taylor Wessing
    Zoe Butler
    Powell Gilbert

LMG Life Sciences is a sister publication to Managing IP, and is run independently from IP Stars research.



more from across site and SHARED ros bottom lb

More from across our site

Deals between five more law firms and President Trump and an antitrust lawsuit against Amgen were also among the top talking points this week
US counsel explain how they win new cleantech IP business and how they’re navigating the industry’s challenges
Leaders at the IP firms, which have joined forces with backing from a PE investor, share their vision of building the number one pan-European IP practice
Firms will steer clients towards other ways of getting quicker examinations, but fear the ramifications of the USPTO’s decision
Melissa Haapala added that returning to client advocacy and the chance to work on patent litigation were reasons for returning to private practice
Michelle Clark, who has a generalist litigation background, plans to focus on IP disputes at Alston & Bird
Philips and Vivo have entered into a licensing agreement, putting an end to a five-year-old telecom SEP dispute in India
Stefan Müller discusses managing deadlines, the importance of reflection, and why IP is more than just a 'nice to have'
The three founders of the IP firm’s new US offering say they plan to offer a unique proposition in a market fixated by the billable hour
The opinion provides useful guidance when it comes to how courts might consider contributory infringement, DMCA claims, and other issues in AI copyright cases
Gift this article